Individualized Targeting and Neuromodulation of Late-Life Depression

An open-label, single-arm, clinical research study about how to make transcranial magnetic stimulation (TMS), an FDA-approved treatment, more effective for patients with late-life depression using fMRI.

NCT Number	NCT04543773
Lead Sponsor	University of New Mexico Collaborators: The Mind Research Network
Conditions	Major Depressive Disorder
Enrollment	24 participants
Start Date	2024-10-01
Primary Completion	2026-09-01 (estimated)
Study Completion	2026-09-01 (estimated)
Updated on ClinicalTrials.gov	2026-08-04